These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 21695925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs.
    Kirana S, Stratmann B, Lammers D, Negrean M, Stirban A, Minartz P, Koerperich H, Gastens MH, Götting C, Prohaska W, Kleesiek K, Tschoepe D.
    Int J Clin Pract; 2007 Apr; 61(4):690-2. PubMed ID: 17394441
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Spinal cord stimulation in diabetic lower limb critical ischaemia: transcutaneous oxygen measurement as predictor for treatment success.
    Petrakis IE, Sciacca V.
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):587-92. PubMed ID: 10873725
    [Abstract] [Full Text] [Related]

  • 8. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation.
    Nizankowski R, Petriczek T, Skotnicki A, Szczeklik A.
    Kardiol Pol; 2005 Oct; 63(4):351-60; discussion 361. PubMed ID: 16273471
    [Abstract] [Full Text] [Related]

  • 9. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE, Sciacca V.
    Int Surg; 1999 Oct; 84(2):122-8. PubMed ID: 10408282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Complications impaired endothelial progenitor cell function in Type 2 diabetic patients with or without critical leg ischaemia: implication for impaired neovascularization in diabetes.
    Chen MC, Sheu JJ, Wang PW, Chen CY, Kuo MC, Hsieh CJ, Chen JF, Chang HW.
    Diabet Med; 2009 Feb; 26(2):134-41. PubMed ID: 19236615
    [Abstract] [Full Text] [Related]

  • 12. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M, Sadamoto K, Yokoyama A, Yamanaka T, Onodera R, Kuroda A, Baba R, Kaneko Y, Tsukie T, Kurimoto Y, Okada Y, Kihara Y, Morioka S, Fukushima M, Asahara T.
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic factors for critical limb ischemia after autologous bone marrow implantation].
    Oda M, Kato K, Toba K, Otaki K, Kitajima T, Ikarashi N, Yanagawa T, Higashimura M, Asami F, Isoda M, Ozawa T, Moriyama M, Hirono S, Okura Y, Hanawa H, Kodama M, Aizawa Y.
    J Cardiol; 2007 Oct; 50(4):235-42. PubMed ID: 17987839
    [Abstract] [Full Text] [Related]

  • 14. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients.
    Kirana S, Stratmann B, Prante C, Prohaska W, Koerperich H, Lammers D, Gastens MH, Quast T, Negrean M, Stirban OA, Nandrean SG, Götting C, Minartz P, Kleesiek K, Tschoepe D.
    Int J Clin Pract; 2012 Apr; 66(4):384-93. PubMed ID: 22284892
    [Abstract] [Full Text] [Related]

  • 15. Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia.
    Dubský M, Jirkovská A, Bem R, Němcová A, Fejfarová V, Hazdrová J, Sutoris K, Chlupáč J, Skibová J, Jude EB.
    Diabet Med; 2019 Sep; 36(9):1133-1140. PubMed ID: 31077439
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia].
    Gu Y, Zhang J, Qi L.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651
    [Abstract] [Full Text] [Related]

  • 17. [Transcutaneous oxygen tension in hyperbaric condition as a predictor of ischaemia in non-healing diabetic foot ulcers].
    Cechurová D, Rusavý Z, Lacigová S, Růzicka J, Novák M, Jankovec Z.
    Vnitr Lek; 2002 Oct; 48(10):971-5. PubMed ID: 16737148
    [Abstract] [Full Text] [Related]

  • 18. Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration.
    Weck M, Rietzsch H, Lawall H, Pichlmeier U, Bramlage P, Schellong S.
    Thromb Haemost; 2008 Sep; 100(3):475-82. PubMed ID: 18766265
    [Abstract] [Full Text] [Related]

  • 19. [The salvage of ischaemic limb by therapeutical angiogenesis].
    Talapková R, Hudecek J, Sinák I, Kubisz P, Laca L, Hlinka L, Zelenák K.
    Vnitr Lek; 2009 Mar; 55(3):179-83. PubMed ID: 19378842
    [Abstract] [Full Text] [Related]

  • 20. Double trouble: infection and ischemia in the diabetic foot.
    Edmonds M.
    Int J Low Extrem Wounds; 2009 Jun; 8(2):62-3. PubMed ID: 19443892
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.